Gain Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.50
|
|
Average Rating
|
4.75
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.46
|
-0.38
|
0.08
|
17.39%
|
|
2022-06-30
|
-0.31
|
-0.43
|
-0.12
|
-38.71%
|
|
2022-03-31
|
-0.37
|
-0.28
|
0.09
|
24.32%
|
|
2021-12-31
|
-0.49
|
-0.32
|
0.17
|
34.69%
|
|
2021-09-30
|
-0.36
|
-0.39
|
-0.03
|
-8.33%
|
|
2021-06-30
|
-0.30
|
-0.30
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.21
|
-0.50
|
-0.29
|
-138.10%
|
|
2020-12-31
|
0.00
|
0.00
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.09
|
|
2021-12-31
|
-1.51
|
|
2020-12-31
|
-0.73
|